ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 662251 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 662251; 2) Community: the network communities that were significantly associated with the response to NSC 662251; 3) Molecule: the relationships between components within communities and NSC 662251; 4) MDR: the compounds that were significantly associated with the NSC 662251.

NSC Compound Enrichment Correlation
NSC 639517 Cyclopentanone, 2-[(4-chlorophenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0187206825450445 0.32854016
NSC 695323 Null 0.0187206825450445 0.19929897
NSC 105132 Deoxycamptothecin 0.0208632511155816 0.030783
NSC 144163 Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- 0.0208632511155816 0.56626225
NSC 15795 Null 0.0208632511155816 -0.12487935
NSC 326061 1-Piperidinecarbothioic acid, 2-ethyl-, [1-(2-pyridinyl)ethylidine]hydrazide 0.0208632511155816 0.31080037
NSC 346098 Null 0.0208632511155816 0.37284088
NSC 603084 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- 0.0208632511155816 0.41529644
NSC 608984 Leucinostatine D 0.0208632511155816 0.24769377
NSC 622596 1,1-Dimethyl-5-(2-naphthalenyl)dithiobiuret 0.0208632511155816 0.23650673
Total:93  Current:40    [First] [Prev] [Next] [Last]